11.04.2016
- Eli Lilly and AstraZeneca are moving into Phase 3 of their Amaranth study of AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor that could be a potential treatment...
20.01.2016
- US green technology company Anellotech and leading consumer beverage firm Suntory Holdings have entered the next phase of their partnership to develop and commercialize 100% bio...
17.11.2015
- US-based drugs firm Janssen Pharmaceuticals has gained worldwide rights, excluding China and Korea, to develop and commercialize oxyntomodulin-based treatments for diabetes and...
